Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway.

Sui H, Pan SF, Feng Y, Jin BH, Liu X, Zhou LH, Hou FG, Wang WH, Fu XL, Han ZF, Ren JL, Shi XL, Zhu HR, Li Q.

BMC Complement Altern Med. 2014 Aug 1;14:279. doi: 10.1186/1472-6882-14-279.

2.

Zuo Jin Wan, a Traditional Chinese Herbal Formula, Reverses P-gp-Mediated MDR In Vitro and In Vivo.

Sui H, Liu X, Jin BH, Pan SF, Zhou LH, Yu NA, Wu J, Cai JF, Fan ZZ, Zhu HR, Li Q.

Evid Based Complement Alternat Med. 2013;2013:957078. doi: 10.1155/2013/957078. Epub 2013 Mar 4.

3.

Baicalin induces apoptosis in leukemia HL-60/ADR cells via possible down-regulation of the PI3K/Akt signaling pathway.

Zheng J, Hu JD, Chen YY, Chen BY, Huang Y, Zheng ZH, Liu TB.

Asian Pac J Cancer Prev. 2012;13(4):1119-24.

4.

Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.

Sims JT, Ganguly SS, Bennett H, Friend JW, Tepe J, Plattner R.

PLoS One. 2013;8(1):e55509. doi: 10.1371/journal.pone.0055509. Epub 2013 Jan 31.

5.

[Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].

Qu F, Xia B, Li X, Guo S, Zhang L, Tian C, Yu Y, Zhang Y.

Zhonghua Zhong Liu Za Zhi. 2015 Jun;37(6):412-7. Chinese.

PMID:
26463142
6.

Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.

Hua H, Chen W, Shen L, Sheng Q, Teng L.

Acta Biochim Biophys Sin (Shanghai). 2013 Sep;45(9):773-9. doi: 10.1093/abbs/gmt071. Epub 2013 Jun 19.

PMID:
23786838
7.

Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.

Cheng Z, Yang N, Liang W, Yan X, Li L, Pan L.

Leuk Lymphoma. 2012 Jul;53(7):1383-9. doi: 10.3109/10428194.2011.650695. Epub 2012 Jan 31.

PMID:
22185283
8.

Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-κB signaling.

Yang X, Ding Y, Xiao M, Liu X, Ruan J, Xue P.

Chem Biol Interact. 2017 Dec 25;278:22-31. doi: 10.1016/j.cbi.2017.10.008. Epub 2017 Oct 5.

PMID:
28987325
9.

Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway.

Sha M, Ye J, Zhang LX, Luan ZY, Chen YB, Huang JX.

Pharmacology. 2014;93(1-2):39-46. doi: 10.1159/000357683. Epub 2014 Jan 15.

PMID:
24434352
10.

Lapatinib inhibits the activation of NF-κB through reducing phosphorylation of IκB-α in breast cancer cells.

Ma C, Zuo W, Wang X, Wei L, Guo Q, Song X.

Oncol Rep. 2013 Feb;29(2):812-8. doi: 10.3892/or.2012.2159. Epub 2012 Nov 29.

PMID:
23229346
11.

Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.

Gao Y, Xiao X, Zhang C, Yu W, Guo W, Zhang Z, Li Z, Feng X, Hao J, Zhang K, Xiao B, Chen M, Huang W, Xiong S, Wu X, Deng W.

J Pineal Res. 2017 Mar;62(2). doi: 10.1111/jpi.12380. Epub 2016 Dec 24.

PMID:
27865009
12.

Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/β-catenin signaling in colorectal cancer cells.

Pan J, Xu Y, Song H, Zhou X, Yao Z, Ji G.

BMC Complement Altern Med. 2017 Nov 28;17(1):506. doi: 10.1186/s12906-017-2006-7.

13.

Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.

Bharadwaj U, Marin-Muller C, Li M, Chen C, Yao Q.

Mol Cancer. 2011 Aug 31;10:106. doi: 10.1186/1476-4598-10-106.

14.

Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.

Song L, Xiong H, Li J, Liao W, Wang L, Wu J, Li M.

Clin Cancer Res. 2011 Apr 1;17(7):1839-49. doi: 10.1158/1078-0432.CCR-10-0720. Epub 2011 Feb 15.

15.

Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.

Wang H, Zhao L, Zhu LT, Wang Y, Pan D, Yao J, You QD, Guo QL.

Mol Carcinog. 2014 Feb;53 Suppl 1:E107-18. doi: 10.1002/mc.22052. Epub 2013 Jun 13.

PMID:
23761018
16.

Retinoic acid promotes proliferation of chicken primordial germ cells via activation of PI3K/Akt-mediated NF-κB signalling cascade.

Yu M, Ge C, Zeng W, Mi Y, Zhang C.

Cell Biol Int. 2012 Aug 1;36(8):705-12. doi: 10.1042/CBI20110542.

PMID:
22548360
17.

PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line.

Tang T, Song X, Liu YF, Wang WY.

Cell Biol Int. 2014 Apr;38(4):502-10. doi: 10.1002/cbin.10169. Epub 2014 Feb 5.

PMID:
23956061
18.

MiR-221 promotes IgE-mediated activation of mast cells degranulation by PI3K/Akt/PLCγ/Ca(2+) pathway.

Xu H, Gu LN, Yang QY, Zhao DY, Liu F.

J Bioenerg Biomembr. 2016 Jun;48(3):293-9. doi: 10.1007/s10863-016-9659-7. Epub 2016 Apr 25.

PMID:
27113449
19.

The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.

Wang H, Wang X, Li Y, Liao A, Fu B, Pan H, Liu Z, Yang W.

Pharmazie. 2012 Feb;67(2):187-92.

PMID:
22512091
20.

Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.

Bai C, Yang X, Zou K, He H, Wang J, Qin H, Yu X, Liu C, Zheng J, Cheng F, Chen J.

Naunyn Schmiedebergs Arch Pharmacol. 2016 Jun;389(6):573-84. doi: 10.1007/s00210-016-1217-7. Epub 2016 Mar 3.

PMID:
26935715

Supplemental Content

Support Center